• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Cosmetic Raw Material
  • Pharmaceutical IntermediatesPharmaceutical intermediates Nutritional Supplements Pharmaceutical raw materials
  • OEM & ODMCapsule Softgel Capsule Gummies Drop & drinks Tables
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Anthelmintics Antiviral drugs Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Tenofovir alafenamide hemifumarate raw Powder

    • Tenofovir alafenamide hemifumarate raw Powder
    • Tenofovir alafenamide hemifumarate raw Powder storehouse
    • Tenofovir alafenamide hemifumarate raw Powder quality testing
    • Tenofovir alafenamide hemifumarate raw Powder quality testing
    • Tenofovir alafenamide hemifumarate raw Powder certificate

    Product Overview:

    tenofovir alafenamide (TAF) is a novel nucleotide reverse transcriptase inhibitor developed by Gilead for the treatment of chronic hepatitis B virus infection and compensatory liver disease.
    tenofovir Elafolamine is an oral prodrug of Tenofovir (TFV) and an improved version of tenofovirdisoproxil fumarate (TDF). Compared with TDF, TAF has a smaller clinical dose and is easier to enter cells to play its role. The antiviral effect is stronger and the adverse reactions are reduced.

    Tenofovir alafenamide hemifumarate raw Powder Attributes

    Tenofovir alafenamide hemifumarate Raw Powder

    CAS:1392275-56-7

    MF:C25H33N6O9P

    Tenofovir alafenamide hemifumarate

    MW:592.55

    EINECS:805-448-8

    Specification​: 99% min Tenofovir alafenamide hemifumarate

    Sample:Tenofovir alafenamide hemifumarate Powder

    Packaging:1kg/bag, 25kg/drum

    Brand: Henrikang

    Appearance:white

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Tenofovir alafenamide hemifumarate raw Powder Details

    Tenofovir alafenamide hemifumarate Usage and Synthesis.

    Tenofovir fumarate Alafolamine (TAF), an oral nucleoside transcriptase inhibitor developed by Gilead, is another prodrug to Tenofovir dipifurate fumarate (TDF), developed for Hepatitis B virus infection (HBV) and acquired immune syndrome (HIV).

    Tenofovir alafenamide hemifumarate powder

    Uses of Tenofovir alafenamide hemifumarate.

    Tenofovir Elafolamine fumarate can be used as a solvent, alkylation, esterification and polymerization catalyst. 99% of the products are mainly used in medicine, and 70% of the products are mainly used in the electroplating industry. Nutritional drugs, combined with low-protein diet, prevent and treat the damage caused by protein metabolism disorders caused by chronic renal insufficiency, chronic renal insufficiency and wasting malnutrition.

    Tenofovir alafenamide hemifumarate

    In vitro study of Tenofovir alafenamide hemifumarate.

    Product Method of Tenofovir alafenamide hemifumarate.

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,